Hims & Hers Health, Inc.
Hims & Hers Health, Inc. (NYSE: HIMS) operates a consumer-first digital health and wellness platform that transforms how customers access routine medical care and health products. Founded in 2017, the company has facilitated over fifty million telehealth consultations across the United States, Canada, the United… From the company’s description.
Margins and return on equity change in ; everything else in percent. Fewer shares and less debt are shown plainly, not as bad news — it depends what you make of buybacks. Dotted labels explain each measure. is shown separately from the annual figures.
What Hims & Hers Health, Inc. does
In the company’s own words
Hims & Hers Health, Inc. (NYSE: HIMS) operates a consumer-first digital health and wellness platform that transforms how customers access routine medical care and health products. Founded in 2017, the company has facilitated over fifty million telehealth consultations across the United States, Canada, the United Kingdom, and the European Union, including Germany, Ireland, France, and Spain. The company's website is www.himshers.com.
The platform provides access to licensed healthcare professionals who deliver personalized treatment plans for chronic conditions including sexual health, hair loss, hormone health, weight loss, dermatology, and mental health. Hims & Hers also offers comprehensive laboratory testing services and a range of non-prescription health and wellness products. The company's integrated technology infrastructure includes an electronic medical record system, digital prescription capabilities, cloud pharmacy fulfillment, and proprietary personalization algorithms designed to support both patients and clinicians.
The business model centers on subscription-based recurring revenue, allowing customers to select shipment cadences ranging from every thirty days to annually. The company operates wholly-owned pharmacies including two licensed 503A pharmacies, two UK General Pharmaceutical Council-licensed pharmacies, a 503B compounding outsourcing facility, a peptide manufacturing facility, and a laboratory testing services facility. These integrated operations enable seamless drug delivery, supply chain oversight, and increased operating leverage while reducing costs typically associated with third-party pharmacy relationships.
Due to corporate practice of medicine restrictions in most U.S. states, Hims & Hers contracts with separate Affiliated Medical Groups owned by physicians to provide clinical services rather than directly employing providers. In the United Kingdom and Ireland, where no such restrictions exist, the company directly employs physicians through its subsidiaries. The company maintains partnerships with leading health systems and operates established retail partnerships in the United Kingdom through Asda and Superdrug.
The company's growth strategy focuses on acquiring new customers through omnichannel marketing, expanding within its existing customer base, launching new specialty offerings, leveraging its integrated pharmacy and laboratory capabilities, and expanding internationally. In February 2026, Hims & Hers announced a definitive agreement to acquire Eucalyptus, an Australia-based digital health company operating across multiple geographies.
Company details
- Sector
- Health Care
- Industry (SIC)
- Health Services
- Headquarters
- SAN FRANCISCO, CA
- Fiscal year end
- December
- CIK
- 1773751
- SIC
- 8011
Financial performance, year by year
Fiscal 2020–2025 · USDThe full income statement, balance sheet and cash flow for each of these years — every figure traceable to its filing — is on the Financials tab with a free account.
Who owns Hims & Hers Health, Inc. — and what changed
Funds as of 2026Q2 · superinvestors as of 2026-06-30
Largest fund holders · Hims & Hers Health, Inc.’s weight in each
Fund ownership is a floor, not a census — pensions, insurers and people holding shares directly are not visible here.
Hims & Hers Health, Inc.’s bonds, as funds hold them
Funds report holding 2 issues of Hims & Hers Health, Inc.’s debt, $91.71M at market value — what funds hold, not the company’s total debt.
Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.
Every fund and institutional holder, quarter by quarter, is on the Ownership tab with a free account.
Recent filings
All filings →Each filing opens into its own statements and disclosures here.
Put this business in context.
Compare this company with peers, find it in your funds and follow its financial history with your connected AI:
- “How do Hims & Hers Health, Inc. and its peers compare on margins and cash generation over ten years?”
- “Where did five years of Hims & Hers Health, Inc.'s earnings go — cash, debt, buybacks, reinvestment?”
- “What changed in Hims & Hers Health, Inc.'s last four quarterly filings that the numbers alone won't show?”